TipRanks
Advertisement
Advertisement

DE:640 Stock Latest News

China Resources Pharma Subsidiary KPC Wins Approval for RMB1 Billion Medium-Term Note Program
Company AnnouncementsChina Resources Pharma Subsidiary KPC Wins Approval for RMB1 Billion Medium-Term Note Program
1M ago
China Resources Pharma unit posts H1 2026 unaudited results tied to onshore bond issues
PremiumCompany Announcements
China Resources Pharma unit posts H1 2026 unaudited results tied to onshore bond issues
1M ago
CR Pharmaceutical subsidiary posts unaudited interim results tied to PRC bond issuance
PremiumCompany Announcements
CR Pharmaceutical subsidiary posts unaudited interim results tied to PRC bond issuance
1M ago
China Resources Pharmaceutical Posts Stable Interim Profit and Higher Revenue
PremiumCompany Announcements
China Resources Pharmaceutical Posts Stable Interim Profit and Higher Revenue
1M ago
China Resources Pharmaceutical Declares Interim Dividend with Currency Option
PremiumCompany Announcements
China Resources Pharmaceutical Declares Interim Dividend with Currency Option
1M ago
China Resources Pharma Flags Sharp Interim Loss at KPC Subsidiary
PremiumCompany AnnouncementsChina Resources Pharma Flags Sharp Interim Loss at KPC Subsidiary
1M ago
CR Sanjiu H1 2026 Profit Declines Amid Modest Revenue Growth, Dividend Proposed
Premium
Company Announcements
CR Sanjiu H1 2026 Profit Declines Amid Modest Revenue Growth, Dividend Proposed
1M ago
Tasly Pharmaceutical Posts Strong Profit and Cash Flow Despite Flat Revenue
Premium
Company Announcements
Tasly Pharmaceutical Posts Strong Profit and Cash Flow Despite Flat Revenue
1M ago
CR Jiangzhong Posts Lower Interim Earnings but Boosts Operating Cash Flow and Keeps Dividend
PremiumCompany Announcements
CR Jiangzhong Posts Lower Interim Earnings but Boosts Operating Cash Flow and Keeps Dividend
1M ago
CR Double-Crane Posts Softer Interim Earnings but Maintains Dividend Payout
PremiumCompany Announcements
CR Double-Crane Posts Softer Interim Earnings but Maintains Dividend Payout
1M ago
CR Boya’s Interim Results Show Sharp Profit and Cash Flow Declines
PremiumCompany Announcements
CR Boya’s Interim Results Show Sharp Profit and Cash Flow Declines
1M ago
China Resources Pharma Subsidiary Dong-E-E-Jiao Posts Profit Growth but Operating Cash Slumps
PremiumCompany Announcements
China Resources Pharma Subsidiary Dong-E-E-Jiao Posts Profit Growth but Operating Cash Slumps
2M ago
China Resources Pharmaceutical Sets August Board Meeting for Interim Results and Dividend Review
PremiumCompany AnnouncementsChina Resources Pharmaceutical Sets August Board Meeting for Interim Results and Dividend Review
2M ago
China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier Chemical
Premium
Company Announcements
China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier Chemical
2M ago
China Resources Pharmaceutical Raises RMB1 Billion in Second Tranche of 2026 Medium-Term Notes
Premium
Company Announcements
China Resources Pharmaceutical Raises RMB1 Billion in Second Tranche of 2026 Medium-Term Notes
2M ago
China Resources Pharmaceutical Raises RMB1 Billion via Medium-Term Notes in Mainland China
PremiumCompany Announcements
China Resources Pharmaceutical Raises RMB1 Billion via Medium-Term Notes in Mainland China
2M ago
China Resources Pharma Leads Bid for Strategic Stake in Lier Chemical
PremiumCompany Announcements
China Resources Pharma Leads Bid for Strategic Stake in Lier Chemical
3M ago
Tasly Delivers Profit Growth on Flat Revenue, Bolstering China Resources Pharmaceutical
PremiumCompany Announcements
Tasly Delivers Profit Growth on Flat Revenue, Bolstering China Resources Pharmaceutical
3M ago
CR Sanjiu’s First-Half 2026 Profit Declines Despite Revenue Growth
PremiumCompany Announcements
CR Sanjiu’s First-Half 2026 Profit Declines Despite Revenue Growth
3M ago
China Resources’ KPC Warns of Steep First‑Half Loss Amid Policy and Market Pressures
PremiumCompany AnnouncementsChina Resources’ KPC Warns of Steep First‑Half Loss Amid Policy and Market Pressures
3M ago
China Resources Pharmaceutical Refreshes Board With New Non-Executive Director
Premium
Company Announcements
China Resources Pharmaceutical Refreshes Board With New Non-Executive Director
3M ago
China Resources Pharmaceutical Details Board and Committee Structure
Premium
Company Announcements
China Resources Pharmaceutical Details Board and Committee Structure
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >